Lexicon Pharmaceuticals Inc
LXRX
Market Cap$327.22M
Close$
$-0.39
143.5% downside
Current Fair Value
143.5% downsideOvervalued by 143.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $327.22 Million |
|---|---|
| Enterprise Value | $362.08 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.63 |
| Beta | 1.01 |
| Outstanding Shares | 362,073,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.84 |
|---|---|
| PEG | 3.85 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 11.6 |
| Enterprise Value to EBIT | -2.07 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | 0.79 |
Revenue Sources
No data
Insider Trades
ESG Score
No data